Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00015102
DRKS00015102
Completed
Not Applicable

Quantitative Sensory Testing (QST) to establish a somatosensory phenotype in pulmonary surgery - Identification of risk factors and a sensitive predictor in QST testing for chronic post-thoracotomy pain and its neuropathic component.

niversitätsmedizin Essen, Ruhrlandklinik0 sites182 target enrollmentJuly 17, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG89.22: Chronic post-thoracotomy pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G89.22: Chronic post-thoracotomy pain
Sponsor
niversitätsmedizin Essen, Ruhrlandklinik
Enrollment
182
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 17, 2018
End Date
August 31, 2017
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Essen, Ruhrlandklinik

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing elective thoracic surgery at the Department of Thoracic Surgery and Thoracic Endoscopy at the Ruhrlandklinik.

Exclusion Criteria

  • •\- Communication difficulties prohibiting the investigation/ questionnaires
  • •\- drug abuse
  • •\- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)J84.9R07.4Interstitial pulmonary disease, unspecifiedChest pain, unspecified
DRKS00022978niversitätsmedizin Essen, Ruhrlandklinik79
Completed
Not Applicable
Quantitative sensory testing (QST) protocol.
NL-OMON34703PRA International EDS400
Recruiting
Not Applicable
Quantitative Sensory Testing (QST) in The Diagnostic & Therapeutic Process of patients with Painful Cervical Facet ArthropathyChronic Neck Pain1002321310005944
NL-OMON34812niversitair Medisch Centrum Sint Radboud92
Active, not recruiting
Phase 1
Evaluation of sensory testing to measure the effects of tetrodotoxipainTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
CTIS2022-500318-24-00eiden University Medical Center25
Active, not recruiting
Phase 2
Tetrodotoxin and quantitative sensory testing in healthy volunteersPainSigns and Symptoms
ISRCTN78737401eiden University Medical Center25